CNN —

The latest results from a trial of a pill form of popular GLP-1 medications offer enough information for Eli Lilly to request global regulatory approval this year, the company said Tuesday.

Lilly, which makes the injectable drugs Zepbound to treat obesity and Mounjaro and Trulicity to treat diabetes, is among several companies chasing an effective pill form of such GLP-1 receptor agonists. In May , the US Food and Drug Administration accepted Novo Nordisk's marketing application for an oral version of its weight-loss drug Wegovy, with a decision expected toward the end of the year. Latest Forecast

° F FEELS LIKE No weather data available

HOURLY

DAILY RADAR TRAFFIC

The only semaglutide pill that's currently available, Rybelsus , treats type 2 diabetes an

See Full Page